These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 6433104
1. [Use of dibunol in the therapy of ischemic heart disease]. Dudchenko MA, Rasin MS, Kazakov IuM, Shkliar AS. Klin Med (Mosk); 1984 Jun; 62(6):77-9. PubMed ID: 6433104 [No Abstract] [Full Text] [Related]
2. [Effect of the antioxidant, ionol, on blood coagulation in ischemic heart disease]. Shkliar AS. Vrach Delo; 1980 Sep; (9):52-4. PubMed ID: 7423951 [No Abstract] [Full Text] [Related]
3. [Effect of the antioxidant dibunol on the composition and lipid peroxidation intensity of the blood of ischemic heart disease patients]. Sal'nikov MI, Barsel' VA, Arkhipova GV. Dokl Akad Nauk SSSR; 1984 Sep; 278(3):747-51. PubMed ID: 6499651 [No Abstract] [Full Text] [Related]
4. [Comparative evaluation of the anti-arrhythmia effect of the antioxidant ionol (dibunol) in the arrhythmic form of neurocirculatory asthenia and stable exertion-induced stenocardia]. Meerson FZ, Korochkin IM, Barbarash OL. Sov Med; 1990 Sep; (3):67-70. PubMed ID: 1695023 [No Abstract] [Full Text] [Related]
5. [Action of dibunol, isoptin and their combination in transitory myocardial ischemia in waking rabbits]. Koniurev EA. Farmakol Toksikol; 1987 Sep; 50(1):61-4. PubMed ID: 3556553 [Abstract] [Full Text] [Related]
6. [Effect of dibunol on plasma, erythrocyte and thrombocyte coagulating and fibrinolytic activity]. Gol'denberg IuM. Fiziol Zh (1978); 1980 Sep; 26(5):695-7. PubMed ID: 7428973 [No Abstract] [Full Text] [Related]
8. [Significance of sarcolemma damage in the pathogenesis of myocardial ischemia induced by pituitrin-isadrin and its correction using the antioxidant dibunol]. Konorev EA, Pichugin VV, Sharov VG, Tolokol'nikov AV. Biull Eksp Biol Med; 1986 Nov; 102(11):532-4. PubMed ID: 2430640 [Abstract] [Full Text] [Related]
11. [Clinical effectiveness of depot nitroglycerin preparations in ischemic heart disease patients]. Grigor'iants RA, Lupanov VP, Samoĭlenko LE, Lobova NM. Ter Arkh; 1984 Nov; 56(4):67-70. PubMed ID: 6427964 [No Abstract] [Full Text] [Related]
12. [Long-term effects of nitroglycerin on the heart and peripheral vessels in patients with coronary disease during rest and in frequency-induced angina pectoris]. Westermann KW, Langbehn AF, Kugler G. Verh Dtsch Ges Kreislaufforsch; 1974 Nov; 40():458-61. PubMed ID: 4217505 [No Abstract] [Full Text] [Related]
13. [The anti-ulcer action of dibunol (Tonarol)]. Zarudiĭ RF, Myshkin VA, Zarudiĭ FS, Ismagilova AF, Davydova VA. Eksp Klin Farmakol; 1998 Nov; 61(5):21-3. PubMed ID: 9854627 [Abstract] [Full Text] [Related]
14. Angina pectoris and nitroglycerin. Braun P. Ther Hung; 1974 Nov; 22(4):187-8. PubMed ID: 4219455 [No Abstract] [Full Text] [Related]
15. [Effect of the antioxidant dibunol on the course of a neurodystrophic process in the rat pancreas]. Bykov AV, Stroganova AB, Shashirina MI. Biull Eksp Biol Med; 1989 May; 107(5):568-70. PubMed ID: 2736291 [Abstract] [Full Text] [Related]
16. [Action of the antioxidant dibunol on disordered deamination reactions of nitrogenous compounds in the heart muscle in experimental hyperthyroidism]. Khuzhamberdiev M, Saĭdullaev T, Aleksandrov NG, Gerasimov NF, Gorkin VZ. Patol Fiziol Eksp Ter; 1988 May; (2):30-3. PubMed ID: 3412803 [No Abstract] [Full Text] [Related]
17. [Treatment of erosive-ulcerous disorders of the upper gastrointestinal tract with dibunol]. Emanuél' NM, Andrianova OP, Sokolov LK, Korman DB, Krutova TV. Sov Med; 1986 May; (6):96-9. PubMed ID: 3750058 [No Abstract] [Full Text] [Related]